Li-Xin Guo (Lixin Guo)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Glycemic Control

Peripheral Nerve

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Oxidative medicine and cellular longevity

Diabetes therapy : research, treatment and education of diabetes and related disorders

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism (2024)
Li-Xin Guo, Yue Xi, Li Li, Kunquan Guo, Jun Wu, Jiawei Xu, Yihua Wang, Guangyu Wu, Si Si
Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus. Diabetes, obesity & metabolism 26 (7) (2024)
Li-Xin Guo, Yue Xi, Li Li, Kunquan Guo, Jun Wu, Jiawei Xu, Yihua Wang, Guangyu Wu, Si Si
Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus. Diabetes, obesity & metabolism (2024)
Weihao Wang, Jingtao Qiao, Lina Zhang, Jie Zhang, Jingyi Luo, Chen Chen, Xiaoxia Wang, Peng Jia, Jia Zhang, Qi Pan, Li-Xin Guo
Prevalence of very high cardiovascular disease risk in patients with type 2 diabetes mellitus: A population-based cross-sectional screening study. Diabetes, obesity & metabolism (2024)
Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Li-Xin Guo, Yue Xi, Li Li, Kunquan Guo, Jun Wu, Jiawei Xu, Yihua Wang, Guangyu Wu, Si Si
Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus. Diabetes, obesity & metabolism 26 (7) (2024)
Li-Xin Guo, Lian-Wei Wang, De-Zeng Tian, Feng-Mei Xu, Wei Huang, Xiao-Hong Wu, Wei Zhu, Jun-Qiu Chen, Xin Zheng, Hai-Yan Zhou, Hong-Mei Li, Zhong-Chen He, Wen-Bo Wang, Li-Zhen Ma, Jun-Ting Duan
Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Yijun Li, Dongni Yu, Li-Xin Guo, Yi-Ming Mu, Hailong Wan, Junfen Wang, Binhua Xu, Guoping Wang, Chengxia Jiang, Li Liang, Jiewen Zhang, Jingcheng Liu, Minlu Zhang, Nan Cui
Efficacy and safety of basal-first titration order in individuals with type 2 diabetes receiving short-term intensive insulin therapy: An exploratory analysis of BEYOND V. Diabetes, obesity & metabolism (2023)
Li-Xin Guo, Li Li, Qiurong Yu, Na Wang, Jun Chen, Yue Xi, Huan Wang, Yihua Wang, Jiawei Xu
Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study. Diabetes, obesity & metabolism (2023)
Yijun Li, Dongni Yu, Li-Xin Guo, Yi-Ming Mu, Hailong Wan, Junfen Wang, Binhua Xu, Guoping Wang, Chengxia Jiang, Li Liang, Jiewen Zhang, Jingcheng Liu, Minlu Zhang, Nan Cui
Efficacy and Safety of Basal-First Titration Order in Individuals with Type 2 Diabetes Receiving Short-Term Intensive Insulin Therapy: An Exploratory Analysis of BEYOND V. Diabetes, obesity & metabolism (2023)
Qi Pan, Yijun Li, Hailong Wan, Junfen Wang, Binhua Xu, Guoping Wang, Chengxia Jiang, Li Liang, Wei Feng, Jingcheng Liu, Ting Wang, Xia Zhang, Nan Cui, Yi-Ming Mu, Li-Xin Guo, null null
Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial. Diabetes, obesity & metabolism 24 (10) (2022)
Li-Xin Guo, Li Li, Qiurong Yu, Na Wang, Jun Chen, Zhiquan Wang, Yuchen Ding
Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN). Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (6) (2022)
Jie Zhang, Tong-Zhang Xian, Yu Teng, Xiuzhi Wang, Ming-Xiao Wu, Chen Li, Weihao Wang, Fuli Man, Xianbo Zhang, Xiaoxia Wang, Li-Xin Guo
Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus. International journal of clinical practice 2022 (2022)
Jingyi Luo, Xiaoxia Wang, Li Yuan, Li-Xin Guo
Association of thyroid disorders with gestational diabetes mellitus: a meta-analysis. Endocrine 73 (3) (2021)
Jingyi Luo, Xiaoxia Wang, Li Yuan, Li-Xin Guo
Genome‑wide profiling of DNA methylation and gene expression unravel the epigenetic landscape in diabetes-related hypothyroidism. Clinical epigenetics 13 (1) (2021)
Jingwen Fan, Qi Pan, Qun Gao, Wenqing Li, Fei Xiao, Li-Xin Guo
TSH Combined with TSHR Aggravates Diabetic Peripheral Neuropathy by Promoting Oxidative Stress and Apoptosis in Schwann Cells. Oxidative medicine and cellular longevity 2021 (2021)
Qinghua He, Xiuzhi Wang, Caizhe Yang, Xiaoming Zhuang, Yanfen Yue, Hongjiang Jing, Jing Hu, Mingxiao Sun, Li-Xin Guo
Metabolic and Nutritional Characteristics in Middle-Aged and Elderly Sarcopenia Patients with Type 2 Diabetes. Journal of diabetes research 2020 (2020)
Yi Zeng, Qi Pan, Xiaoxia Wang, Dongxiao Li, Yajun Lin, Fuli Man, Fei Xiao, Li-Xin Guo
Impaired Mitochondrial Fusion and Oxidative Phosphorylation Triggered by High Glucose Is Mediated by Tom22 in Endothelial Cells. Oxidative medicine and cellular longevity 2019 (2019)
Li-Xin Guo, Li Chen, Baocheng Chang, Liyong Yang, Yu Liu, Bo Feng
A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study. Diabetes, obesity & metabolism 20 (12) (2018)
Xiaofan Jia, Xiaogang Wang, Xiaoxia Wang, Qi Pan, Tongzhang Xian, Xiaobin Yu, Li-Xin Guo
In Vivo Corneal Confocal Microscopy Detects Improvement of Corneal Nerve Parameters following Glycemic Control in Patients with Type 2 Diabetes. Journal of diabetes research 2018 (2018)